SEC Form 4 · accession 0001127602-18-026018
AVIENT CORP · AVNT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert M Patterson
Officer — Chairman, President & CEO · Director
Period of report
Aug 20, 2018
Accepted (ET)
Aug 22, 2018 · 5:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001122976
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 20, 2018 | M | 30,500 | $14.81 | A | 290,179 | D | |
| Common Stock | Aug 20, 2018 | D | 19,352 | $43.16 | D | 270,827 | D | |
| Common Stock | Aug 20, 2018 | M | 48,800 | $14.61 | A | 319,627 | D | |
| Common Stock | Aug 20, 2018 | D | 30,837 | $43.16 | D | 288,790 | D | |
| Common Stock | Aug 20, 2018 | M | 30,700 | $23.08 | A | 319,490 | D | |
| Common Stock | Aug 20, 2018 | D | 22,752 | $43.16 | D | 296,738 | D | |
| Common Stock | Aug 20, 2018 | M | 20,500 | $35.07 | A | 317,238 | D | |
| Common Stock | Aug 20, 2018 | D | 18,363 | $43.16 | D | 298,875 | D | |
| Common StockF2 | Aug 21, 2018 | S | 20,000 | $43.6075 | D | 278,875 | D | |
| Common StockF3 | Aug 22, 2018 | S | 19,196 | $43.3015 | D | 259,679 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF4 | $14.81 | Aug 20, 2018 | M | 30,500 | D | — | Feb 16, 2021 | Common Stock | 30,500 | 0 | D |
| Stock Appreciation RightsF5 | $14.61 | Aug 20, 2018 | M | 48,800 | D | — | Feb 14, 2022 | Common Stock | 48,800 | 0 | D |
| Stock Appreciation RightsF6 | $23.08 | Aug 20, 2018 | M | 30,700 | D | — | Feb 15, 2023 | Common Stock | 30,700 | 0 | D |
| Stock Appreciation RightsF7 | $35.07 | Aug 20, 2018 | M | 20,500 | D | — | Feb 11, 2024 | Common Stock | 20,500 | 0 | D |
Explanation of responses
- F1Includes shares acquired pursuant to dividend reinvestment since the last Form 4 was filed.
- F2The sale price is a weighted average for the sale transactions. The sales prices range from a low of $43.21 per share to a high of $43.89. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, PolyOne Corporation or a security holder of PolyOne Corporation.
- F3The sale price is a weighted average for the sale transactions. The sales prices range from a low of $43.12 per share to a high of $43.52 per share. Full information regarding the number of shares sold at each separate price is available upon request by the Commission staff, PolyOne Corporation, or a security holder of PolyOne Corporation.
- F4The stock appreciation rights vested in three equal annual installments beginning February 16, 2012.
- F5SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $14.61 per share and no more than one-third of the grant can vest per year during the first three years.
- F6SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $23.08 per share and no more than one-third of the grant can vest per year during the first three years.
- F7SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.